Nanoform Finland (STU:4YL) Research & Development: €1.64 Mil (TTM As of Mar. 2026)


STU:4YL Nanoform Finland PLC STU:4YL
67 GF Score
Price €0.77
GF Value €1.77
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is Nanoform Finland Research & Development?

Nanoform Finland STU:4YL -5.84% 67 Research & Development is €1.64 Mil as of Mar. 2026. GuruFocus rates STU:4YL with a GF Score™ of 67/100 and a GF Value™ of €1.77 (Possible Value Trap). The stock has 4 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Nanoform Finland's Research & Development for the three months ended in Mar. 2026 was €0.24 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 was €1.64 Mil.

Nanoform Finland  (STU:4YL) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Nanoform Finland Research & Development Related Terms

Nanoform Finland Research & Development Historical Data

* Premium members only.

The historical data trend for Nanoform Finland's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Nanoform Finland Research & Development Chart

Nanoform Finland Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.93 1.01 1.00 1.56 1.99

Nanoform Finland Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.59 0.56 0.46 0.38 0.24
STU:4YL
67GF Score
Nanoform Finland PLC STU:4YL
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Nanoform Finland Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €1.64 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of €1.64 Mil mean?
Nanoform Finland (STU:4YL) has a Research & Development of €1.64 Mil as of Mar. 2026. Research and development expense is the total cost for research and development activities. View historical data on Nanoform Finland and its competitors.
Is Nanoform Finland's Research & Development too high?
Nanoform Finland's current Research & Development is €1.64 Mil. Overall, Nanoform Finland has a GF Score™ of 67/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Nanoform Finland's Research & Development compare to VRTX and REGN?
Nanoform Finland's Research & Development of €1.64 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Biotechnology company?
A good Research & Development depends on the Biotechnology industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Nanoform Finland and its competitors. Nanoform Finland's current Research & Development is €1.64 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nanoform Finland stock overvalued right now?
Based on GuruFocus' analysis, Nanoform Finland (STU:4YL) is currently considered Possible Value Trap. The stock's GF Value™ is €1.77, compared to a current price of €0.77 — trading 56.3% below its estimated fair value. The current Research & Development is €1.64 Mil. Nanoform Finland's overall GF Score™ is 67/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Nanoform Finland (STU:4YL), the current Research & Development is €1.64 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Nanoform Finland (STU:4YL) Overvalued in 2026?

Based on GuruFocus' analysis, Nanoform Finland stock appears to be undervalued. The current stock price of €0.77 is trading 56.3% below its estimated GF Value™ of €1.77. GuruFocus considers Nanoform Finland to be Possible Value Trap.

Key valuation signals for STU:4YL:

  • Research & Development: €1.64 Mil
  • GF Value™: €1.77 vs. price of €0.77 (56.3% below fair value)
  • GF Score™: 67/100 with 4 warning signs

No single metric tells the full story. See the STU:4YL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Nanoform Finland Business Description

Address Cultivator II, Viikinkaari 4, Helsinki, FIN, 00790
Nanoform Finland PLC is a nanoparticle medicine-enabling company. The company works together with pharma and biotech partners to reduce attrition in clinical trials and enhance their molecules' formulation performance through its nano-forming services. Its patented and scalable Controlled Expansion of Supercritical Solutions (CESS) technology produces nano-formed API particles as small as 10nm. This enables poorly soluble molecules in the pharmaceutical pipeline to progress into clinical development by increasing their rate of dissolution and improving their bioavailability. Its technology provides novel opportunities in many value-enhancing drug delivery applications. Geographically, the company generates maximum revenue from Europe, followed by the United States and other regions.
67GF Score

Get the complete analysis for STU:4YL

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.77
Price
€1.77
GF Value